Hot Pursuit     03-Mar-23
Kiri Inds spurts after Singapore court's ruling on DyStar's final valuation
Kiri Industries hit an upper circuit of 10% at Rs 335.90 after the Singapore International Commercial Court confirmed $603.80 million as the final value of the company's stake in DyStar.

In a statement filed with the bourses today, the company announced that the Singapore International Commercial Court (SICC) vide its judgement dated 3 March 2023, confirmed the final value of company's 37.57% stake in DyStar Global Holdings (Singapore) (DyStar) as $603.80 million as against US$481.60 million, which was valued by the SICC vide its judgement dated 21 June 2021, which is now significantly increased by $122.20 million.

The court of appeal (the Supreme Court of Singapore) vide its judgement dated 6 July 2022 had decided two major points in favour of the Company related to 19% discount for lack of marketability and notional licence fees with respect to exploitation of DyStar's patent by Longsheng and had directed the SICC to give effect of the said Judgement.

“The buyout order is to be executed now at the value of US$ 603.80 million by Senda International Capital Ltd,” Kiri Industries said in a statement.

Kiri Industries had filed a suit against Senda International Capital regarding its minority stake held in DyStar. Following the suit, the International court had directed Senda to buyout Kiri's minority stake held in DyStar.

In making the buyout order, the SICC held that the value of Kiri's shareholding was to take into consideration the effects of various aspects of oppressive conduct by Zhejiang Longsheng Group Co ("Longsheng"), of which Senda was a wholly-owned subsidiary. The SICC's decision was upheld on appeal (see Senda International Capital v Kiri Industries and others and another appeal [2019] 2 SLR.

Further proceedings then took place before the SICC to determine how Kiri's shareholding was to be valued for the purposes of the buyout order. The SICC delivered various judgments for the valuation proceedings.

These appeals by both Senda and Kiri raise issues arising out of those judgments concerning matters affecting the valuation of DyStar and adjustments for various factors as well as the valuation of Kiri's shareholding and adjustments relevant to that.

Kiri Industries is one of the largest manufacturer and exporter of wide range of dyes, intermediates and chemicals from India.

Previous News
  Kiri Industries to table results
 ( Corporate News - 06-Feb-24   17:10 )
  Kiri Industries consolidated net profit declines 85.39% in the June 2019 quarter
 ( Results - Announcements 13-Aug-19   17:26 )
  Kiri Industries consolidated net profit rises 1.70% in the September 2019 quarter
 ( Results - Announcements 14-Nov-19   09:06 )
  Board of Kiri Industries to consider conversion of FCCBs
 ( Corporate News - 04-Aug-21   11:47 )
  Motherson Sumi Systems Ltd leads losers in 'A' group
 ( Hot Pursuit - 03-Jun-21   15:00 )
  Kiri Industries standalone net profit rises 1102.27% in the December 2016 quarter
 ( Results - Announcements 28-Jan-17   15:08 )
  Kiri Industries to hold board meeting
 ( Corporate News - 17-May-17   10:31 )
  Kiri Industries reports net loss of Rs 17.26 crore in the December 2012 quarter
 ( Results - Announcements 13-Feb-13   09:48 )
  Kiri Industries reports consolidated net profit of Rs 111.91 crore in the March 2020 quarter
 ( Results - Announcements 30-Jun-20   13:47 )
  Kiri Industries incorporates wholly owned subsidiary in Singapore
 ( Corporate News - 14-Feb-24   12:14 )
  Kiri Industries announces board meeting date
 ( Corporate News - 24-May-22   10:02 )
Other Stories
  Marico's domestic biz sees modest volume growth in Q1
  06-Jul-24   12:25
  Titan revenue rises 9% YoY, adds 61 stores in Q1
  06-Jul-24   11:09
  Dabur India expects mid to high digit revenue growth in Q1
  06-Jul-24   10:40
  Dhanlaxmi Bank gains as gross advances rises 6% YoY in Q1 FY25
  05-Jul-24   15:27
  HDFC Bank Ltd leads losers in 'A' group
  05-Jul-24   15:00
  Shilpa Medicare sizzles after Unicycive gets positive results in clinical trials of OLC
  05-Jul-24   14:52
  Manugraph India Ltd leads losers in 'B' group
  05-Jul-24   14:45
  NSE SME Nephro Care India rallies on listing day
  05-Jul-24   14:45
  ESAF SFB total deposits jumps 33% YoY in Q1
  05-Jul-24   14:43
  Utkarsh SFB deposits climb 30% YoY in Q1 FY25
  05-Jul-24   14:35
Back Top